Differentiation Between Pdac Patients And Healthy Controls Using Serum

Differentiation between PDAC patients and healthy controls using serum ...
Differentiation between PDAC patients and healthy controls using serum ...
Differentiation between PDAC patients and healthy controls using serum ...
Differentiation between PDAC patients and healthy controls using serum ...
Comparison between PD patients and healthy controls using the ...
Comparison between PD patients and healthy controls using the ...
Comparison of serum survivin levels in healthy controls and patients ...
Comparison of serum survivin levels in healthy controls and patients ...
Differences between patients (PD) and healthy controls (HC). | Download ...
Differences between patients (PD) and healthy controls (HC). | Download ...
| (A) EV EpCAM expression in serum samples from PDAC patients and ...
| (A) EV EpCAM expression in serum samples from PDAC patients and ...
SROC curves for PDAC vs healthy controls (A) and PDAC vs benign disease ...
SROC curves for PDAC vs healthy controls (A) and PDAC vs benign disease ...
SROC curves for PDAC vs healthy controls (A) and PDAC vs benign disease ...
SROC curves for PDAC vs healthy controls (A) and PDAC vs benign disease ...
Proportion of immunoreactivity. While healthy controls (Co) and PDAC ...
Proportion of immunoreactivity. While healthy controls (Co) and PDAC ...
Plasma lipid mediator profiling from patients with PDAC and healthy ...
Plasma lipid mediator profiling from patients with PDAC and healthy ...
Metabolomic signatures in serum of patients with dCCA, PDAC or BPD and ...
Metabolomic signatures in serum of patients with dCCA, PDAC or BPD and ...
Galectin-9 serum levels discriminate PDAC patients from benign ...
Galectin-9 serum levels discriminate PDAC patients from benign ...
suPAR serum levels are elevated in PDAC patients. (A) PDAC patients ...
suPAR serum levels are elevated in PDAC patients. (A) PDAC patients ...
Overview of study design for the differentiation of PDAC patients (T ...
Overview of study design for the differentiation of PDAC patients (T ...
Classification of patients with PDAC vs. healthy control individuals ...
Classification of patients with PDAC vs. healthy control individuals ...
Serum exosomal and serum GPC-1 expression levels in patients with ...
Serum exosomal and serum GPC-1 expression levels in patients with ...
Metabolite set enrichment analysis (MSEA) compared between controls and ...
Metabolite set enrichment analysis (MSEA) compared between controls and ...
Classification of patients with PDAC vs. healthy control individuals ...
Classification of patients with PDAC vs. healthy control individuals ...
Overview of study design for the differentiation of PDAC patients (T ...
Overview of study design for the differentiation of PDAC patients (T ...
Model statistics for the healthy pancreas and the PDAC models (A ...
Model statistics for the healthy pancreas and the PDAC models (A ...
Distributions of CA199 and CTCs in PDAC patients and controls. (A, C ...
Distributions of CA199 and CTCs in PDAC patients and controls. (A, C ...
Cross-talk between PDAC cells and TME. PDAC cells have been shown to ...
Cross-talk between PDAC cells and TME. PDAC cells have been shown to ...
Model statistics for the healthy pancreas and the PDAC models (A ...
Model statistics for the healthy pancreas and the PDAC models (A ...
Identification of DECs. a The volcano plot of DECs between PDAC and ...
Identification of DECs. a The volcano plot of DECs between PDAC and ...
Demographic data and biochemical measurements in PDAC patients and ...
Demographic data and biochemical measurements in PDAC patients and ...
Activin A is highly expressed in tumor specimens from PDAC patients and ...
Activin A is highly expressed in tumor specimens from PDAC patients and ...
Changes of nMDSC subsets in PBMC of PDAC patients after operation and ...
Changes of nMDSC subsets in PBMC of PDAC patients after operation and ...
Composition of basement membrane in healthy and PDAC patients. (a ...
Composition of basement membrane in healthy and PDAC patients. (a ...
(A) Serum levels of BAFF were determined in patients with PDAC (n = 44 ...
(A) Serum levels of BAFF were determined in patients with PDAC (n = 44 ...
Distributions of CA199 and CTCs in PDAC patients and controls. (A, C ...
Distributions of CA199 and CTCs in PDAC patients and controls. (A, C ...
Inclusion and exclusion of PDAC patients to analyze sex-dependent gene ...
Inclusion and exclusion of PDAC patients to analyze sex-dependent gene ...
Overlapped DEGs and pathways between PDAC and ANT in five datasets. (A ...
Overlapped DEGs and pathways between PDAC and ANT in five datasets. (A ...
Biomarker panel quantification in early-stage PDAC patients and in ...
Biomarker panel quantification in early-stage PDAC patients and in ...
Plasma s(P)RR levels in patients with PDAC and amounts in the ...
Plasma s(P)RR levels in patients with PDAC and amounts in the ...
Clinicopathological data of the PDAC, PNET patients and controls ...
Clinicopathological data of the PDAC, PNET patients and controls ...
The serum C4BPA and PIGR levels are increased in PDAC patients. (A ...
The serum C4BPA and PIGR levels are increased in PDAC patients. (A ...

Loading image details...

Source
Dimensions